Bamco Inc. NY Has $13.18 Million Stock Position in Tempus AI, Inc. (NASDAQ:TEM)

Bamco Inc. NY increased its position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 72.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 390,400 shares of the company's stock after acquiring an additional 164,600 shares during the quarter. Bamco Inc. NY owned 0.25% of Tempus AI worth $13,180,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in TEM. Wells Fargo & Company MN grew its stake in Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock valued at $80,000 after purchasing an additional 278 shares in the last quarter. Operose Advisors LLC bought a new position in shares of Tempus AI in the fourth quarter valued at approximately $25,000. Prestige Wealth Management Group LLC lifted its stake in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after buying an additional 965 shares during the last quarter. Farther Finance Advisors LLC bought a new stake in shares of Tempus AI during the 4th quarter worth $34,000. Finally, First Horizon Advisors Inc. grew its stake in Tempus AI by 207.9% in the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock valued at $55,000 after buying an additional 1,108 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company's stock.

Insider Buying and Selling

In other Tempus AI news, Director Jennifer A. Doudna sold 1,320 shares of the company's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $90.00, for a total transaction of $118,800.00. Following the sale, the director now directly owns 36,011 shares of the company's stock, valued at approximately $3,240,990. This represents a 3.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Ryan Fukushima sold 20,000 shares of the business's stock in a transaction that occurred on Tuesday, February 4th. The stock was sold at an average price of $62.50, for a total value of $1,250,000.00. Following the completion of the transaction, the chief operating officer now directly owns 962,442 shares in the company, valued at $60,152,625. The trade was a 2.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,408,938 shares of company stock worth $262,986,880 in the last 90 days. 27.60% of the stock is owned by company insiders.

Tempus AI Trading Up 10.0 %

NASDAQ:TEM opened at $57.06 on Monday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The firm has a 50-day moving average price of $48.11 and a 200 day moving average price of $50.66. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $91.45.

Analyst Ratings Changes

A number of research firms have weighed in on TEM. Wolfe Research lowered shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Guggenheim reissued a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. BTIG Research started coverage on Tempus AI in a report on Monday, April 21st. They issued a "buy" rating and a $60.00 target price on the stock. Morgan Stanley lifted their price target on Tempus AI from $50.00 to $60.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Finally, JPMorgan Chase & Co. cut Tempus AI from an "overweight" rating to a "neutral" rating and increased their price objective for the company from $50.00 to $55.00 in a research report on Tuesday, February 25th. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $61.08.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.